Sernova Corp OTC Stock Top Insiders
SEOVF Stock | USD 0.31 0.02 6.06% |
Sernova Corp employs about 14 people. The company is managed by 14 executives with a total tenure of roughly 90 years, averaging almost 6.0 years of service per executive, having 1.0 employees per reported executive. Examination of Sernova Corp's management performance can provide insight into the company performance.
Philip Toleikis CEO CEO and President and Director |
Sernova |
Sernova Corp Management Team Effectiveness
The company has return on total asset (ROA) of (0.3759) % which means that it has lost $0.3759 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.6454) %, meaning that it generated substantial loss on money invested by shareholders. Sernova Corp's management efficiency ratios could be used to measure how well Sernova Corp manages its routine affairs as well as how well it operates its assets and liabilities.Sernova Corp Workforce Comparison
Sernova Corp is rated below average in number of employees category among related companies. The total workforce of Health Care industry is at this time estimated at about 7,332. Sernova Corp adds roughly 14.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Sernova Corp Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Sernova Corp Price Series Summation is a cross summation of Sernova Corp price series and its benchmark/peer.
Sernova Corp Notable Stakeholders
A Sernova Corp stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Sernova Corp often face trade-offs trying to please all of them. Sernova Corp's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Sernova Corp's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Philip Toleikis | CEO and President and Director | Profile | |
Ralph Deiterding | CFO | Profile | |
Scott Langille | CFO | Profile | |
Sean Hodgins | CFO | Profile | |
Bruce Weber | Director | Profile | |
James Parsons | Director | Profile | |
Jeffrey Bacha | Independent Director | Profile | |
Frank Holler | Director | Profile | |
Douglas Maret | Chief Officer | Profile | |
Ray Matthews | IR Contact Officer | Profile | |
CA CA | Chief Officer | Profile | |
Christopher Barnes | VP Relations | Profile | |
Frank MBA | Ex Chairman | Profile | |
BA MSc | CEO Pres | Profile |
About Sernova Corp Management Performance
The success or failure of an entity such as Sernova Corp often depends on how effective the management is. Sernova Corp management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sernova management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sernova management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company was incorporated in 1998 and is headquartered in London, Canada. Sernova Corp operates under Biotechnology classification in the United States and is traded on OTC Exchange.
The data published in Sernova Corp's official financial statements usually reflect Sernova Corp's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Sernova Corp. For example, before you start analyzing numbers published by Sernova accountants, it's critical to develop an understanding of what Sernova Corp's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Sernova Corp's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sernova Corp's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Sernova Corp's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Sernova Corp. Please utilize our Beneish M Score to check the likelihood of Sernova Corp's management manipulating its earnings.
Sernova Corp Workforce Analysis
Traditionally, organizations such as Sernova Corp use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Sernova Corp within its industry.Sernova Corp Manpower Efficiency
Return on Sernova Corp Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 1.7M | |
Net Loss Per Executive | 1.7M | |
Working Capital Per Employee | 159.6K | |
Working Capital Per Executive | 159.6K |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sernova Corp. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Sernova OTC Stock analysis
When running Sernova Corp's price analysis, check to measure Sernova Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sernova Corp is operating at the current time. Most of Sernova Corp's value examination focuses on studying past and present price action to predict the probability of Sernova Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sernova Corp's price. Additionally, you may evaluate how the addition of Sernova Corp to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |